About Path Central
Path Central is a company based in Irvine (United States) founded in 2009 was acquired by Xifin in August 2013. Path Central has raised $14.91 million across 3 funding rounds from investors including Xifin, Okapi Venture Capital and Arboretum Ventures. Path Central operates in a competitive market with competitors including Waters Corporation, Deciphex, Ovation, Labvantage and Labforward, among others.
- Headquarter Irvine, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Path Central
Path Central has successfully raised a total of $14.91M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $1.91 million completed in November 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Path Central
Path Central has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Xifin, Okapi Venture Capital and Arboretum Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US focused VC investment company
|
Locked | Locked | Locked | |
|
Healthcare venture capital investments are made by Arboretum Ventures.
|
Locked | Locked | Locked | |
|
Global private equity and venture capital investments in B2B Tech & Services companies.
|
Locked | Locked | Locked |
Investor details for Path Central
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Path Central
Investment portfolio details for Path Central
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Path Central
Detailed financials for Path Central
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Path Central Comparisons
Peer comparison for Path Central
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Path Central
Path Central operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Waters Corporation, Deciphex, Ovation, Labvantage and Labforward, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of laboratory management system for researchers and clinicians
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
Cloud-based platform for laboratory data management and collaboration is provided.
|
|
| Locked | Locked | Locked |
LIMS, Quality ELN and Business Intelligence solutions for laboratory
|
|
| Locked | Locked | Locked |
Laboratory collaboration platforms for data, devices, and researchers are provided.
|
|
| Locked | Locked | Locked |
Provider of data driven drug discovery and development platform for various industries
|
Detailed competitors of Path Central
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Path Central
Complete news archive for Path Central
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Path Central
Path Central was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Path Central is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Path Central is a funded company, having raised a total of $14.91M across 3 funding rounds to date.
Path Central was founded in 2009 in Irvine, United States, as a technology company focused on pathology software. A web-based Laboratory Information System is offered, integrating ordering, workflow management, specimen tracking, transcription, diagnosis, reporting, billing, and financial analysis for pathology practices. The company was acquired by XIFIN in August 2013.
Path Central's top competitors include Deciphex, Ovation and Waters Corporation.
Path Central has 4 investors. Key investors include Xifin, Okapi Venture Capital, Arboretum Ventures, and Baird Capital.